Global Partnering

Autism Therapeutics considers attracting strategic commercialization partnerships with leading pharmaceutical companies for AT001 in select regions globally as key to its strategic vision.

Autism Therapeutics has both developed a clear expertise in autism clinical development and attracted leading international scientists in the field, and is interested in developing partnerships with pharmaceutical companies that have compounds with mechanisms of actions that may address known affected pathways in autism.